Clinical Trial Update: Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy [Phase 1, Phase 2]

View source ↗

Summary

The document reports results from a completed Phase 1/2 trial evaluating subantimicrobial-dose doxycycline for Graves' ophthalmopathy (Graves' disease).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Graves Ophthalmopathy
• Hyperthyroidism

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Graves Ophthalmopathy, Graves Disease | Phase 1, Phase 2 | Status: COMPLETED